latest news releases from the newsroom
TMNG Global Reports 2009 First Quarter Results
OVERLAND PARK, Kan., May 14, 2009 (GLOBE NEWSWIRE) -- TMNG Global (Nasdaq:TMNG), a leading provider of management consulting and software solution services to the global communications, media and entertainment industries, reported financial results for its 2009 first quarter ended April 4, 2009.
Tufco Technologies, Inc.
Tufco Technologies, Inc. Announces Fiscal Year 2009 Second Quarter and First Six Months Results
GREEN BAY, Wis., May 14, 2009 (GLOBE NEWSWIRE) -- Tufco Technologies, Inc. (Nasdaq:TFCO), the largest contract converter of branded wet and dry wipes in North America and a leader in specialty printing services and business imaging products, today announced that fiscal year 2009 second quarter sales were $19,455,000, down 34% over fiscal year 2008 second quarter sales. For the first six months of 2009, sales were $42,641,000, compared to $54,422,000 for the 2008 first six months, a decrease of 22%.
Volterra Semiconductor Corporation
Volterra to Present At JMP and UBS Conferences
FREMONT, Calif., May 14, 2009 (GLOBE NEWSWIRE) -- Volterra Semiconductor Corporation (Nasdaq:VLTR), a leading provider of high-performance analog and mixed-signal power management semiconductors, today announced that Mike Burns, Vice President of Finance and CFO, will be presenting at the Eighth Annual JMP Securities Research Conference at the Ritz-Carlton Hotel in San Francisco on Wednesday, May 20, 2009 at 11:30 AM PDT. In addition, Jeff Staszak, President and CEO, will present at the UBS Global Technology and Services Conference at the Sheraton New York Hotel & Towers in New York on Tuesday, June 9, 2009 at 1:45 PM EDT.
Medicis Pharmaceutical Corporation
Medicis to Present At Deutsche Bank Health Care Conference
SCOTTSDALE, Ariz., May 14, 2009 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the Deutsche Bank 34th Annual Health Care Conference in Boston, Massachusetts. A live webcast of its presentation scheduled for Monday, May 18, 2009, at 10:00 a.m. Eastern Time (7:00 a.m. Pacific Time), may be accessed via the Internet.
Endurance Specialty Holdings Ltd.
Endurance's Board of Directors Declares Quarterly Dividend of $0.25 Per Ordinary Share and $0.484375 Per Series A Preferred Share
PEMBROKE, Bermuda, May 14, 2009 (GLOBE NEWSWIRE) -- Endurance Specialty Holdings Ltd. (NYSE:ENH), a Bermuda-based provider of property and casualty insurance and reinsurance, today announced that its Board of Directors declared a quarterly dividend of $0.25 per ordinary share and $0.484375 per share payable on its 7.75% Non-Cumulative Preferred Shares, Series A. The dividend on Endurance's outstanding ordinary shares will be payable on June 30, 2009 to the ordinary shareholders of record on June 16, 2009 and the dividend on Endurance's Series A Preferred Shares will be payable on June 15, 2009 to the Series A Preferred shareholders of record on June 1, 2009.
STARLIMS Technologies Ltd.
STARLIMS to Present At the Eighth Annual JMP Securities Research Conference On Tuesday, May 19, 2009
HOLLYWOOD, Fla., May 14, 2009 (GLOBE NEWSWIRE) -- STARLIMS Technologies Ltd. (Nasdaq:LIMS), a leading provider of laboratory information management systems, or LIMS, announced that its chief executive officer, Itschak Friedman, and its chief financial officer, Chaim Friedman, will present a corporate overview at the Eighth Annual JMP Securities Research Conference in San Francisco.
Crown Castle International Corp.
Crown Castle International to Present At the Barclays Capital Worldwide Wireless and Wireline Conference
HOUSTON, May 14, 2009 (GLOBE NEWSWIRE) -- Crown Castle International Corp. (NYSE:CCI) announced today that Ben Moreland, Crown Castle's President and Chief Executive Officer is scheduled to present on Wednesday, May 27, 2009 at 3:45 p.m. eastern time at the Barclays Capital Worldwide Wireless and Wireline Conference. Mr. Moreland's presentation will be broadcast live over the Internet and is expected to last approximately 30 minutes. The live audio webcast link and presentation for the conference will be available on Crown Castle's website at http://www.crowncastle.com, where it will also be archived for replay.
Cyclacel Pharmaceuticals Reports Financial Results for First Quarter 2009
BERKELEY HEIGHTS, N.J., May 14, 2009 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP), a cancer drug development stage company, today announced financial results for the first quarter ended March 31, 2009. The Company's net loss for the quarter was $5.1 million or $0.25 per share. Product sales in the quarter were $0.2 million. As of March 31, 2009, the Company had $20.4 million in cash and cash equivalents.